ASX: Appendix form 4C

Stem Cell Sciences plc 31 July 2007 Rule 4.7B Appendix 4C Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 30/9/2001, 24/10/2005. Name of entity Stem Cell Sciences Plc ARBN Quarter ended ("current quarter") ------------------- --------------------------------- 121 989 599 30 June 2007 ------------------- --------------------------------- Consolidated statement of cash flows (rate of exchange £1GBP=2.483 A$) ------------------------------ Cash flows related to operating activities Current quarter Year to date $A'000 6.months $A'000 ------------------------------ 1.1 Receipts from customers 310 996 1.2 Payments for (a) staff costs (569) (1,356) (b) advertising and marketing - - (c) research and development (1,080) (1,907) (d) leased assets - - (e) other working capital (911) (1,616) 1.3 Dividends received - - 1.4 Interest and other items of a similar nature received 102 161 1.5 Interest and other costs of finance paid - (7) 1.6 Income taxes paid - - 1.7 Other (provide details if material) - - --------------------------- Net operating cash flows (2,148) (3,729) -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- Current Year to date quarter 6 months $A'000 $A'000 -------------------------------------------------------------------------------- 1.8 Net operating cash flows (carried forward) (2,148) (3,729) -------------------------------------------------------------------------------- Cash flows related to investing activities 1.9 Payment for acquisition of: - - (a) businesses (item 5) - - (b) equity investments - - (c) intellectual property (15) (20) (d) physical non-current assets - - (e) other non-current assets Proceeds from disposal of: - - (a) businesses (item 5) - - (b) equity investments - - (c) intellectual property - - (d) physical non-current assets - - (e) other non-current assets - - 1.11 Loans to other entities - - 1.12 Loans repaid by other entities - - 1.13 Other (provide details if material) - - ------------ ------------ Net investing cash flows (15) (20) ------------ ------------ 1.14 Total operating and investing cash flows (2,163) (3,749) -------------------------------------------------------------------------------- Cash flows related to financing activities 1.15 Proceeds from issues of shares, options, etc. 10,804 10,804 1.16 Proceeds from sale of forfeited shares - - 1.17 Proceeds from borrowings - - 1.18 Repayment of borrowings - - 1.19 Dividends paid - - 1.20 Other (provide details if material) - - ------------ ------------ Net financing cash flows 10,804 10,804 -------------------------------------------------------------------------------- Net increase (decrease) in cash held 8,641 7,055 1.21 Cash at beginning of quarter/year to date 4,529 6,115 1.22 Exchange rate adjustments to item 1.20 - - -------------------------------------------------------------------------------- 1.23 Cash at end of quarter 13,170 13,170 -------------------------------------------------------------------------------- Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities --------------- Current quarter $A'000 --------------- 1.24 Aggregate amount of payments to the parties included in 422 item 1.2 --------------- 1.25 Aggregate amount of loans to the parties included in item - 1.11 -------------------------------------------------------------------------------- 1.26 Explanation necessary for an understanding of the transactions -------------------------------------------------------------------------------- N/A -------------------------------------------------------------------------------- Non-cash financing and investing activities 2.1 Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows -------------------------------------------------------------------------------- N/A -------------------------------------------------------------------------------- 2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest -------------------------------------------------------------------------------- N/A -------------------------------------------------------------------------------- Financing facilities available Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2). ---------------- ---------------- Amount available Amount used $A'000 $A'000 ---------------- ---------------- 3.1 Loan facilities - - ---------------- ---------------- 3.2 Credit standby arrangements - - -------------------------------------------------------------------------------- Reconciliation of cash ------------ ------------- Reconciliation of cash at the end of the quarter (as Current Previous shown in the consolidated statement of cash flows) to quarter quarter the related items in the accounts is as follows. $A'000 $A'000 -------------------------------------------------------------------------------- 4.1 Cash on hand and at bank 13,170 4,529 ------------ ------------- 4.2 Deposits at call - - ------------ ------------- 4.3 Bank overdraft - - ------------ ------------- 4.4 Other (provide details) - - -------------------------------------------------------------------------------- Total: cash at end of quarter (item 1.23) 13,170 4,529 -------------------------------------------------------------------------------- Acquisitions and disposals of business entities ----------------- ------------------ Acquisitions Disposals (Item 1.9(a)) (Item 1.10(a)) ----------------- ------------------ 5.1 Name of entity - - ----------------- ------------------ 5.2 Place of incorporation or - - registration ----------------- ------------------ 5.3 Consideration for - - acquisition or disposal ----------------- ------------------ 5.4 Total net assets - - ----------------- ------------------ 5.5 Nature of business - - ----------------- ------------------ Compliance statement 1 This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX. 2 This statement does give a true and fair view of the matters disclosed. Sign here: Date: 30th July 2007 Company Secretary Print name: SUSAN FURBER This information is provided by RNS The company news service from the London Stock Exchange

Companies

SThree (STEM)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today